Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
28 studies found for:    " April 14, 2010":" May 14, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" April 14, 2010":" May 14, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: Stribild;   Drug: ATV;   Drug: Ritonavir;   Drug: FTC/TDF;   Drug: Stribild Placebo;   Drug: ATV Placebo;   Drug: RTV Placebo;   Drug: FTC/TDF Placebo
2 Completed
Has Results
Safety and Efficacy of COBI-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: COBI;   Drug: RTV;   Drug: ATV;   Drug: FTC/TDF;   Drug: COBI placebo;   Drug: RTV placebo
3 Completed Extended Follow-Up of Participants in Preventive HIV Vaccine Studies in Uganda
Condition: HIV Infections
Intervention:
4 Completed A New Telemedicine Approach for Chronic HIV/AIDS Patient Home Care
Condition: HIV Infection
Interventions: Other: Virtual Hospital;   Other: Standard of Care
5 Completed
Has Results
Heart Function in HIV-Negative Children Exposed to HIV and HAART
Condition: HIV Infections
Intervention:
6 Terminated A Safety and Immunogenicity Study of 3 Doses of Opal Immunotherapy in HIV Infected People
Condition: HIV Infections
Interventions: Biological: Opal-HIV-Gag(c) Low Dose;   Biological: Opal-HIV-Gag(c) Medium dose;   Biological: Opal-HIV-Gag(c) High dose;   Other: Dimethyl Sulfoxide
7 Unknown  Safety Study of Isentress® + Truvada® in Post-exposure Treatment of HIV Infection
Condition: HIV Infections
Interventions: Drug: raltegravir (Isentress);   Drug: Truvada®
8 Terminated The First Failure Study
Conditions: HIV;   HIV Infections
Interventions: Drug: Darunavir, Ritonavir, Truvada;   Drug: Darunavir, Ritonavir and Etravirine
9 Completed Stonewall Treatment Evaluation Project
Conditions: Substance Abuse;   HIV Infections
Intervention: Behavioral: Stonewall Project
10 Completed Venue-Based Couples CoOp in South Africa
Conditions: Alcoholism;   HIV Infections
Interventions: Behavioral: Couples Intervention;   Behavioral: Women's CoOp;   Behavioral: Women's CoOp and Men's Intervention
11 Completed Safe Drinking Water For Households With Infants Born to HIV-Positive Mothers Pilot Study
Conditions: Diarrhea;   HIV Infection
Intervention: Device: LifeStraw Family
12 Unknown  A Trial to Test the Efficacy of a Tailored Intensive Smoking Cessation Intervention in Persons With HIV (PWHs)
Conditions: Smoking;   HIV Infections;   AIDS
Interventions: Behavioral: Positively Smoke Free;   Behavioral: Standard care
13 Completed HIV Physician's Survey
Condition: HIV
Intervention:
14 Unknown  Evaluation of a Computer-Based System Using Cell Phones for HIV People in Peru
Conditions: HIV;   Adherence;   Sexual Behavior;   HIV Infections
Intervention: Other: Cell phone intervention
15 Completed PK of Tenofovir, Emtricitabine and Efavirenz in Healthy Volunteers
Conditions: HIV Infection;   HIV Infections
Intervention: Drug: Atripla®
16 Recruiting International HIV Antiretroviral Adherence, Resistance and Survival
Condition: HIV/AIDS
Intervention:
17 Completed Plasma and Intracellular Concentrations of Raltegravir and Etravirine Administered Once Daily
Conditions: HIV-1 Infection;   HIV Infections
Interventions: Drug: Raltegravir;   Drug: Etravirine
18 Completed Cardiovascular Diseases in HIV-infected Subjects (HIV-HEART Study)
Conditions: Detection of Frequency, Severity and Progression of Cardiovascular Diseases in Patients With HIV-infection.;   Effect on Cardiovascular Risk and Life Quality by Age, Gender, Classic Cardiovascular Risk Factors,;   HIV-specific Cardiovascular Risk Factors, Cardiovascular Medication, Antiretroviral Medication
Intervention:
19 Completed Intervention Targeting Medication Adherence and Methamphetamine Use in HIV Positive Men (ACE)
Conditions: HIV Medication Adherence;   Methamphetamine Use;   Sexual Risk;   Poly-substance Use;   HIV Infections
Interventions: Behavioral: Motivational Interviewing + Cognitive Behavioral Skills Training;   Behavioral: Education Attention Control
20 Unknown  Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: Raltegravir;   Drug: Atazanavir/Ritonavir

   Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.